Krystal Biotech (KRYS) Short Interest Ratio & Short Volume → The 'Smart Money' Is Ready for May 1st Are You? (From Stansberry Research) (Ad) Free KRYS Stock Alerts $159.05 -2.99 (-1.85%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Krystal Biotech Short Interest DataCurrent Short Volume2,170,000 sharesPrevious Short Volume2,240,000 sharesChange Vs. Previous Month-3.13%Dollar Volume Sold Short$386.11 millionShort Interest Ratio / Days to Cover5.5Last Record DateMarch 31, 2024Outstanding Shares28,510,000 sharesPercentage of Shares Shorted7.61%Today's Trading Volume237,973 sharesAverage Trading Volume259,179 sharesToday's Volume Vs. Average92% Short Selling Krystal Biotech ? Sign up to receive the latest short interest report for Krystal Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatKRYS Short Interest Over TimeKRYS Days to Cover Over TimeKRYS Percentage of Float Shorted Over Time Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. Krystal Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,170,000 shares $386.11 million -3.1%N/A5.5 $177.93 3/15/20242,240,000 shares $387.48 million -10.8%N/A5.8 $172.98 2/29/20242,510,000 shares $400.27 million +1.6%N/A6.5 $159.47 2/15/20242,470,000 shares $280.05 million +21.7%N/A7.3 $113.38 1/31/20242,030,000 shares $225.84 million +3.1%N/A6.6 $111.25 1/15/20241,970,000 shares $252.87 million -9.2%N/A6.3 $128.36 Get the Latest News and Ratings for KRYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter. 12/31/20232,170,000 shares $269.21 million +11.3%N/A7.1 $124.06 12/15/20231,950,000 shares $225.73 million -8.0%N/A6.4 $115.76 11/30/20232,120,000 shares $220.97 million +2.4%N/A6.8 $104.23 11/15/20232,070,000 shares $206.09 million -1.4%N/A6.8 $99.56 10/31/20232,100,000 shares $245.43 million +7.1%N/A7.1 $116.87 10/15/20231,960,000 shares $223.01 million -0.5%N/A7.4 $113.78 9/30/20231,970,000 shares $228.52 million +23.9%N/A7.4 $116.00 9/15/20231,590,000 shares $191.07 million +6.0%N/A5.9 $120.17 8/31/20231,500,000 shares $186.72 million -2.6%N/A5.7 $124.48 8/15/20231,540,000 shares $187.82 million +15.8%N/A5.3 $121.96 7/31/20231,330,000 shares $171.70 million -7.6%N/A4.1 $129.10 7/15/20231,440,000 shares $181.83 million +6.7%6.8%4.7 $126.27 6/30/20231,350,000 shares $158.49 million +3.1%6.4%4.5 $117.40 6/15/20231,310,000 shares $163.37 million +10.1%6.2%4.3 $124.71 5/31/20231,190,000 shares $140.24 million +3.5%5.6%4.3 $117.85 5/15/20231,150,000 shares $103.56 million -0.9%5.5%4.4 $90.05 4/30/20231,160,000 shares $97.44 million -7.2%5.5%5.7 $84.00 4/15/20231,250,000 shares $107.98 million +4.2%6.0%6.4 $86.38 3/31/20231,200,000 shares $96.07 million +5.3%5.8%5.9 $80.06 3/15/20231,140,000 shares $83.80 million -4.2%5.5%5.9 $73.51 2/28/20231,190,000 shares $97.47 million +6.3%5.7%6.3 $81.91 2/15/20231,120,000 shares $82.33 million +6.7%5.4%6.5 $73.51 1/31/20231,050,000 shares $87.28 million -7.1%5.1%6.1 $83.12 1/15/20231,130,000 shares $93.73 million +14.4%5.4%6.5 $82.95 12/30/2022988,100 shares $78.28 million -10.2%4.8%5.9 $79.22 12/15/20221,100,000 shares $86.24 million -9.1%5.3%6.9 $78.40 11/30/20221,210,000 shares $94.07 million -3.2%5.9%7.8 $77.74 11/15/20221,250,000 shares $96.51 million -4.6%6.1%7.7 $77.21 10/31/20221,310,000 shares $100.22 million +3.2%6.4%7.9 $76.50 10/15/20221,270,000 shares $83.83 million -3.1%6.2%7.6 $66.01 9/30/20221,310,000 shares $91.31 million +7.4%6.4%7.9 $69.70 9/15/20221,220,000 shares $86.97 million -4.7%6.3%7.3 $71.29 8/31/20221,280,000 shares $89.74 million -5.9%6.6%7.2 $70.11 8/15/20221,360,000 shares $105.48 million -0.7%7.0%7.9 $77.56Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.See his shocking evidence in this new report KRYS Short Interest - Frequently Asked Questions What is Krystal Biotech's current short interest? Short interest is the volume of Krystal Biotech shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 2,170,000 shares of KRYS short. Learn More on Krystal Biotech's current short interest. What is a good short interest ratio for Krystal Biotech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRYS shares currently have a short interest ratio of 6.0. Learn More on Krystal Biotech's short interest ratio. Is Krystal Biotech's short interest increasing or decreasing? Krystal Biotech saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 2,170,000 shares, a decrease of 3.1% from the previous total of 2,240,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Krystal Biotech's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Krystal Biotech: CRISPR Therapeutics AG (17.39%), Halozyme Therapeutics, Inc. (6.28%), Immunovant, Inc. (14.92%), ImmunityBio, Inc. (41.52%), Iovance Biotherapeutics, Inc. (21.08%), Revolution Medicines, Inc. (7.29%), SpringWorks Therapeutics, Inc. (14.45%), Apogee Therapeutics, Inc. (13.11%), Arcellx, Inc. (9.85%), Immunocore Holdings plc (9.49%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Krystal Biotech stock? Short selling KRYS is an investing strategy that aims to generate trading profit from Krystal Biotech as its price is falling. KRYS shares are trading down $2.99 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Krystal Biotech? A short squeeze for Krystal Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRYS, which in turn drives the price of the stock up even further. How often is Krystal Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRYS, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CRSP Short Interest Data HALO Short Interest Data IMVT Short Interest Data IBRX Short Interest Data IOVA Short Interest Data RVMD Short Interest Data SWTX Short Interest Data APGE Short Interest Data ACLX Short Interest Data IMCR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRYS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceGreat Crypto BullWeiss RatingsFed launches fourth dollar overhaulStansberry Research